Astrazeneca Pharma India Ltd.

View in App
3493.95 +12.35 ▲0.4%

09 June 2023, 04:01:00 PM
Volume: 327

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.astrazenecaindia.com/india
Market Cap 8,679.00 Cr.
Enterprise Value(EV) 8,178.52 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 39.72 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 87.41 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 235.48 Trailing Twelve Months Ending 2023-03
Price to Book Value 14.74 Calculated using Price: 3,471.60
Dividend Yield 0.46 Period Ending 2022-03
No. of Shares Subscribed 2.50 Cr. 25,000,000 Shares
FaceValue 2
About Astrazeneca Pharma India Ltd.
The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. AstraZeneca Pharma India is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC.

Astrazeneca Pharma India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Astrazeneca Pharma India Ltd. Performance

View details >>
1 Day
+0.35%
1 Week
-0.16%
1 Month
+8.84%
3 Month
+4.69%
6 Month
+3.38%
1 Year
+17.30%
2 Year
-7.56%
5 Year
+196.76%
10 Year
+350.57%

Astrazeneca Pharma India Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -0.38 -12.93 3.43 10.63 11.12 20.03 21.83 22.83 12.78
Return on Capital Employed (%) -12.93 3.76 18.74 18.65 26.53 34.61 31.24 17.36
Return on Assets (%) -0.14 -5.04 1.25 4.25 4.76 9.34 10.57 11.31 6.65

Astrazeneca Pharma India Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 172 151 156 223 247 301 364 456 511 589
Non Curr. Liab. 0 1 39 89 110 23 44 45 74 -8
Curr. Liab. 244 260 234 202 219 268 367 373 392 384
Minority Int.
Equity & Liab. 416 412 429 514 575 591 776 874 977 964
Non Curr. Assets 141 148 162 250 243 178 193 186 212 129
Curr. Assets 275 263 267 263 333 413 582 689 765 835
Misc. Exp. not W/O
Total Assets 416 412 429 514 575 591 776 874 977 964

Astrazeneca Pharma India Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 474 517 564 544 571 728 832 814 806 1,003
Other Income 10 8 7 14 12 16 13 13 15 26
Total Income 484 525 571 558 583 745 845 826 820 1,029
Total Expenditure -487 -531 -547 -507 -525 -657 -711 -678 -719 -838
PBIDT -4 -6 23 51 59 88 134 148 101 191
Interest -1 -1 -1 -1
Depreciation -10 -15 -17 -16 -15 -15 -19 -20 -17 -16
Taxation -1 -1 -15 -18 -18 -42 -34 -21 -35
Exceptional Items 14 -40
PAT -1 -21 5 20 26 54 72 93 62 99
Adjusted EPS 0 -8 2 8 10 22 29 37 25 40

Astrazeneca Pharma India Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -6 -1 -46 57 38 9 55 87 105 101
Cash Fr. Inv. -16 -15 -19 -4 0 -9 4 -171 173 5
Cash Fr. Finan. -10 86 -1 -6 -9 -9
Net Change -32 71 -64 53 38 -1 59 -90 269 96
Cash & Cash Eqvt 17 88 23 76 115 114 173 84 352 448

Astrazeneca Pharma India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Astrazeneca Pharma India Ltd. Announcements

View details >>
Fri, 09 Jun 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agents of the Company Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the legal representative of the claimant.
Fri, 09 Jun 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We are enclosing herewith the Certificate dated June 6 2023 issued by Integrated Registry Management Services Private Limited Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018.
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find the enclosed document of the Company in relation to the captioned subject.

Astrazeneca Pharma India Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 5 Years High Increase in 5 Years
MFI Above 80 MFI Above 80
Thu, 08 Jun 2023
High Delivery Percentage High Delivery Percentage

Astrazeneca Pharma India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Astrazeneca Pharma India Ltd. FAQ's

What is Astrazeneca Pharma I share price?
Can I buy Astrazeneca Pharma I shares now?
What is the Dividend Yield of Astrazeneca Pharma I?
What is the Market Cap of Astrazeneca Pharma I?
What are the key metrics to analyse Astrazeneca Pharma I?
What is the 52 Week High and Low of Astrazeneca Pharma I?
What is the trend of Astrazeneca Pharma I share price?